SoVIRIP
SoVIRIP is a virus inhibitory peptide with an IC50 of 1.2 μM for HIV-1 . soVIRIP binds to the HIV-1 GP41 fusion peptide and inhibits viral fusion and entry into host cells. soVIRIP has broad-spectrum anti-HIV-1 activities with nontoxicity in zebrafish models. soVIRIP can used for viral infections research[1].
Product Specifications
UNSPSC
12352209
Target
HIV
Related Pathways
Anti-infection
Field of Research
Infection
Smiles
O=C(N[C@@H](CCC(O)=O)C(N[C@@H](C)C(N[C@@H]([C@@H](C)CC)C(N1[C@@H](CCC1)C(N[C@@H](C(C)C)C(N[C@@H](C)C(N[C@@H](CC2=CC=CC=C2)C(N[C@@H](C(C)C)C(N[C@@H](CC3=CC=CC=C3)C(O)=O)=O)=O)=O)=O)=O)=O)=O)=O)[C@H](CC(C)C)N
Molecular Formula
C56H84N10O13
Molecular Weight
1105.33
References & Citations
[1]Zech F, et al. ReaxFF-Guided Optimization of VIRIP-Based HIV-1 Entry Inhibitors. J Phys Chem B. 2025 Apr 17;129 (15) :3788-3795.
Shipping Conditions
Room temperature
Scientific Category
Peptides
Clinical Information
No Development Reported
Isoform
HIV-1
Curated Selection
Explore Other Products
Discover premium biology products from our extensive collection of 20M+ items
MBS1067682-01 0.02 mg (E-Coli)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details 
MBS1067682-02 0.1 mg (E-Coli)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details MBS1067682-03 0.02 mg (Yeast)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details MBS1067682-04 0.1 mg (Yeast)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details 
MBS1067682-05 0.02 mg (Baculovirus)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details MBS1067682-06 0.02 mg (Mammalian-Cell)
Recombinant Serratia proteamaculans Putative aminoacrylate peracid reductase RutC (rutC)
Ask
View Details